Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab

  1. Figuero-Pérez, L.
  2. Olivares-Hernández, A.
  3. Escala-Cornejo, R.A.
  4. Terán-Brage, E.
  5. López-Gutiérrez, Á.
  6. Cruz-Hernández, J.J.
Aldizkaria:
Reumatologia Clinica

ISSN: 1885-1398,  1699-258X

Argitalpen urtea: 2021

Alea: 17

Zenbakia: 10

Orrialdeak: 559-561

Mota: Artikulua

DOI: 10.1016/J.REUMA.2020.06.003 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus